ATH
Click for more information
25.0% 0.3¢ alterity therapeutics limited

VP of Business Development, page-3

  1. mari joh
    274 Posts.
    clock Created with Sketch.
    16/04/16
    14:54
    Post #: 17520771
    Thanks for the link ITM.
    I notice that Birgit is an Expert Reviewer for the EU Commission.
    Also she spent 8.5 years with Merz Pharmaceuticals, most recently as Director Business Development.

    Looks good to me.
    PBT Price at posting: 7.2¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 10  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

SBW Shekel Brainweigh reports a 50% revenue increase in its Retail Innovation suite and delivers the first batch of 20 Smart Bays to Hitachi as part of a larger order
right-arrow Created with Sketch.
BM8 Learn of the ASX-listed company that is well-placed to respond to the future global energy demand
right-arrow Created with Sketch.
NEWS Positive guidance from the US FDA on Phase III trial
right-arrow Created with Sketch.
NEWS High-grade drilling results at Didievi include 65m at 5.6 g/t gold from 177m, significantly expanding the resource potential at depth
right-arrow Created with Sketch.
NEWS Most viewed thread today: $10m institution led raise to accelerate and expand drilling
right-arrow Created with Sketch.
NEWS Most viewed thread today: $10m institution led raise to accelerate and expand drilling
right-arrow Created with Sketch.
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.3¢ 		Change
-0.001(25.0%) 		Mkt cap ! $15.96M
Open High Low Value Volume
0.4¢ 0.4¢ 0.3¢ $4.734K 1.341M

Buyers (Bids)

No. Vol. Price($)
49 30295639 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 129917446 34
View Market Depth
Last trade - 15.44pm 15/10/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.